Hemodynamic regulation: investigation by spectral analysis.
We investigated the hypothesis that beat-to-beat variability in hemodynamic parameters reflects the dynamic interplay between ongoing perturbations to circulatory function and the compensatory response of short-term cardiovascular control systems. Spontaneous fluctuations in heart rate (HR), arterial blood pressure, and respiration were analyzed by spectral analysis in the 0.02- to 1-Hz frequency range. A simple closed-loop model of short-term cardiovascular control was proposed and evaluated in a series of experiments: pharmacological blockades of the parasympathetic, alpha-sympathetic, beta-sympathetic, and renin-angiotensin systems were used to open the principal control loops in order to examine changes in the spectral pattern of the fluctuations. Atrial pacing was used to examine blood pressure variability in the absence of HR variability. We found that respiratory frequency fluctuations in HR are parasympathetically mediated and that blood pressure fluctuations at this frequency result almost entirely from the direct effect of centrally mediated HR fluctuations. The sympathetic nervous system appears to be too sluggish to mediate respiratory frequency variations. Low-frequency (0.02-0.09 Hz) fluctuations in HR are jointly mediated by the parasympathetic and beta-sympathetic systems and appear to compensate for blood pressure fluctuations at this frequency. Low-frequency blood pressure fluctuations are probably due to variability in vasomotor activity which is normally damped by renin-angiotensin system activity. Blockade of the alpha-adrenergic system, however, does not significantly alter low-frequency blood pressure fluctuations.
D000818:Animals; D001794:Blood Pressure; D002304:Cardiac Pacing, Artificial; D004285:Dogs; D006024:Glycopyrrolate / Q000494:pharmacology; D006339:Heart Rate; D006439:Hemodynamics; D008297:Male; D008955:Models, Cardiovascular; D010275:Parasympathetic Nervous System / Q000187:drug effects / Q000502:physiology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012084:Renin-Angiotensin System / Q000187:drug effects; D012119:Respiration; D013057:Spectrum Analysis; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology; D013722:Teprotide / Q000494:pharmacology; D014666:Vasomotor System / Q000502:physiology
D011433:Propranolol; D013722:Teprotide; D006024:Glycopyrrolate; D010646:Phentolamine